About This Event
Access a free virtual Renal Roundtable program focusing on Early Management of CKD in Type 2 Diabetes Patients. This virtual roundtable featured a moderated discussion of an interdisciplinary panel, including a primary care clinician, endocrinologist, and nephrologist to highlight the disease burden, testing recommendations, available treatments, and new technologies. It also featured engaging case presentations and discussion with the participants. Participation in this event directly supports NKF's goal of advancing programs to improve recognition and management of kidney disease, especially for communities facing health disparities.
Why is this topic so important?
It is estimated that over 2.2 million adults in New York state are living with chronic kidney disease (CKD), approximately 1.9 million remain undiagnosed.
- Diabetes is the leading cause of CKD and hypertension is second leading cause.[i]
- Fewer than 40% of people with diabetes are being tested for CKD according to recommended guidelines. For patients with hypertension its less than 10% of people tested.[ii]
- Many clinicians have the perception that because they are treating diabetes or high blood pressure that they are managing CKD.
- The majority of people with CKD and diabetes and or do not have their diabetes or hypertension controlled.
- Underlying, undiagnosed CKD contributes to breakdowns in diabetes management and optimizing diabetes care starts with awareness of CKD and testing for those at greatest risk.
- With new, game-changing therapies available, it is imperative to get those at-risk tested and appropriated diagnosed.
- There are significant health disparities across the spectrum of kidney disease with Communities of Color being disproportionately affected by these breakdowns in care.[iii]
- Social determinants, including economic insecurity, food insecurity and access to care, contribute to the challenges faced by people living with kidney disease.[iv]